column
    2010, 10(6): 321-321. DOI: 10.3969/j.issn.1671-5144.2010.06.002
    Abstract PDF
    2010, 10(6): 321-321. DOI: 10.3969/j.issn.1671-5144.2010.06.003
    Abstract PDF
    2010, 10(6): 321-321. DOI: 10.3969/j.issn.1671-5144.2010.06.001
    Abstract PDF
    2010, 10(6): 322-322. DOI: 10.3969/j.issn.1671-5144.2010.06.005
    Abstract PDF
    2010, 10(6): 322-322. DOI: 10.3969/j.issn.1671-5144.2010.06.004
    Abstract PDF
    2010, 10(6): 322-322. DOI: 10.3969/j.issn.1671-5144.2010.06.006
    Abstract PDF
    2010, 10(6): 323-323. DOI: 10.3969/j.issn.1671-5144.2010.06.009
    Abstract PDF
    2010, 10(6): 323-323. DOI: 10.3969/j.issn.1671-5144.2010.06.008
    Abstract PDF
    2010, 10(6): 323-323. DOI: 10.3969/j.issn.1671-5144.2010.06.007
    Abstract PDF
    The Meaning of Blood Pressure Variability and the Progress of the Research
    CHEN Lu-yuan
    2010, 10(6): 324-327. DOI: 10.3969/j.issn.1671-5144.2010.06.010
    Abstract PDF
    The Relationships of Intensive Blood-Pressure Control Strategy and Prognostic in Type 2 Diabetes Mellitus
    CHEN Lu-yuan, HUANG Shui-jin, LIU Fu-cheng
    2010, 10(6): 328-332. DOI: 10.3969/j.issn.1671-5144.2010.06.011
    Abstract PDF
    Combination Lipid-Lowering Failed to Make High Cardiovascular Risk in Patients with Type 2 Diabetes Gain——ACCORD Lipid Research Enlightenment
    TAN Hong, DONG Hao-jian
    2010, 10(6): 333-336. DOI: 10.3969/j.issn.1671-5144.2010.06.012
    Abstract PDF
    Effects of Antihypertensive-Drug Class on Interindividual Variation in Blood Pressure and Risk of Stroke
    YU Hui-min, GUO Wei
    2010, 10(6): 337-341. DOI: 10.3969/j.issn.1671-5144.2010.06.013
    Abstract PDF
    Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
    WANG Ling
    2010, 10(6): 342-345. DOI: 10.3969/j.issn.1671-5144.2010.06.014
    Abstract PDF
    Effects of β Blockers and Calcium-Channel Blockers on Within-Individual Variability in Blood Pressure and Risk of Stroke
    FENG Ying-qing
    2010, 10(6): 346-348. DOI: 10.3969/j.issn.1671-5144.2010.06.015
    Abstract PDF
    Efficacy and Safety of Pitavastatin for Hypercholesterolemia: A Systematic Review
    LI Ya-li, XIAO Jia-ling, PENG Hui, MA Bin
    2010, 10(6): 349-354. DOI: 10.3969/j.issn.1671-5144.2010.06.016
    Abstract PDF
    Meta-Analysis of Predictive Value of ERCC1 Protein Expression in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
    WEI Shu-zhen, SHI Yi, SONG Yong
    2010, 10(6): 355-358. DOI: 10.3969/j.issn.1671-5144.2010.06.017
    Abstract PDF
    The Diagnostic Value of IGRA for Latent Tuberculosis Infection in HIV Patients:A Meta-Analysis
    KANG Zhen, SHI Chun-hu, TIAN Jin-hui, YANG Ke-hu
    2010, 10(6): 359-364. DOI: 10.3969/j.issn.1671-5144.2010.06.018
    Abstract PDF
    Interval Confidence and Hypothesis Testing of Median
    LI Ji-bin, ZHANG Jin-xin, LI Wei-dong
    2010, 10(6): 365-368. DOI: 10.3969/j.issn.1671-5144.2010.06.019
    Abstract PDF
    Analysis of Quality Standards Assessing Randomized Controlled Trials
    YANG Sheng-ping, YAN Xian-xia, LIU Jian-qiang, YANG Ke-hu, YUAN Jin-qiu, LIU Ya-li
    2010, 10(6): 369-373. DOI: 10.3969/j.issn.1671-5144.2010.06.020
    Abstract PDF
    Superiority of GLP-1 and its analogues in treating Type 2 Diabetes Mellitus
    YANG Sheng-hua, YANG Hua-zhang
    2010, 10(6): 374-376. DOI: 10.3969/j.issn.1671-5144.2010.06.021
    Abstract PDF
    AAFP Guideline for the Detection and Management of Post-Myocardial Infarction Depression
    ZHENG Yi-ying, GENG Qing-shan
    2010, 10(6): 377-379. DOI: 10.3969/j.issn.1671-5144.2010.06.022
    Abstract PDF
    Comprehensive Therapy for Primary Hepatocellular Carcinoma
    CHEN Wei, HAO Tao, JIAN Zhi-xiang
    2010, 10(6): 380-384. DOI: 10.3969/j.issn.1671-5144.2010.06.023
    Abstract PDF